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Abstract
Background: Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) is an autoimmune disorder presenting with
obsessive compulsive disorder and/or tics. Like Sydenham’s chorea, its presumed pathogenesis consists of autoantibodies cross-reacting with neurons in response to
a group A beta-hemolytic streptococcal infection (GASI). There are currently no diagnostic laboratory findings and management ranges from antibiotic prophylaxis
to intravenous immunoglobulin to plasmapheresis. The diagnosis remains controversial, resulting in inconsistent referrals and significant patient anxiety.
Methods: A retrospective study was performed on all patients referred to the Pediatric Infectious Disease Division with a pre-referral diagnosis of PANDAS.
Patients were analyzed by demographics, medical history, co-morbidities, symptoms, prior treatment, laboratory tests, management strategies, and treatment
outcomes.
Results: From 2003 to 2013, there were 21 patients with a pre-referral diagnosis of PANDAS. Only five met the diagnostic criteria. No patient at referral had an
objective scale to monitor symptoms. Eight referrals had a major psychiatric disorder, and none fulfilled diagnostic criteria (p,0.01).
Discussion: The majority of the patients referred with a pre-diagnosis of PANDAS do not fulfill diagnostic criteria nor do they have objective criteria for symptom
monitoring. Major psychiatric disorders do not seem to be associated with PANDAS, and better physician education may prevent misdiagnoses. Multidisciplinary
management is recommended.
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Introduction
Pediatric autoimmune neuropsychiatric disorder associated with
streptococcal infections (PANDAS) is a disorder that is believed to be
caused by antibodies generated in response to a group A beta-
hemolytic streptococcal infection (GASI) in genetically susceptible
individuals. These antibodies are thought to negatively cross-react with
specific, unidentified neuronal cells resulting in cellular dysfunction
and subsequent neurological symptoms.1–5 The neurologic impair-
ment most classically associated with PANDAS is obsessive compulsive
disorder (OCD) and/or a tic disorder distinguishable from Tourette
syndrome or a chronic tic disorder. This current, albeit controversial,
proposed pathophysiology for PANDAS is similar to that observed
with acute rheumatic fever presenting with Sydenham’s chorea; please
note, it is not the intent of this study to either confirm or challenge this
hypothesis.1–5 However, unlike Sydenham’s chorea, the diagnosis of
PANDAS remains controversial, which results in inconsistent referral
patterns and significant anxiety for the patients and their families.6,7
This familial anxiety frequently results in significant pressure being
placed on referring physicians, who do not have sufficient evidence to
combat internet-driven pressure, to take action.
Current diagnostic criteria for PANDAS include: 1) clinically diagnosed
OCD and/or a tic disorder; 2) documentation of a temporal association
of less than 6 weeks between a GASI and onset of symptoms; 3) multiple
instances of episodic waxing and waning of symptoms in relation to
GASI; and 4) acute onset of symptoms between 3 years of age and
puberty, which was defined as 12 years of age in this study.1–12 Note that
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while the original Swedo criteria were presented as five criteria, in this
study the acute onset and onset before puberty criteria were combined
into one category. The diagnostic criteria for PANDAS have changed
over time, and further complicating the issue is the potential incorporation
of Pediatric Acute-onset Neuropsychiatric Syndrome and Pediatric
Infection-Triggered Autoimmune Neuropsychiatric Disorders, two new
disorders in which an autoimmune response to an infection is linked to
behavioral symptoms, which leads to additional confusion for potential
diagnosticians. There is currently no laboratory findings diagnostic for
PANDAS and proposed management strategies range from antibiotic
treatment of each GASI to antibiotic prophylaxis against streptococcus to
intravenous immunoglobulin (IVIG) to plasmapheresis to electroconvul-
sive therapy (ECT).8 To better understand PANDAS, we sought to assess
both physician referral patterns in relation to the diagnostic criteria and
the management of these patients.
Methods
After obtaining approval from the Institutional Review Board
(IRB) of the University of Michigan Medical School, a retrospective
chart study was performed by one of the authors (C.E.H.) on all
patients referred to the Pediatric Infectious Disease Division at the
University of Michigan with a pre-referral diagnosis of PANDAS
(from 2003 to 2013). Patients were then analyzed by demographics
(age, gender, race, etc.), medical and family history, co-morbidities,
presenting symptoms, prior treatment, laboratory evaluation, and
management strategies and treatment outcomes. Significance was
tested by chi-square analysis, in which a subsection of the pre-
referral diagnosis sample was compared with the sample as a whole.
Results
To date, 21 patients have been referred to the University of
Michigan Division of Pediatric Infectious Diseases with a pre-referral
diagnosis of PANDAS. Patients have been referred here by primary
care physicians, psychiatrists, neurologists, and otolaryngologists. Of
these 21 patients, only five (23.8%) actually met the diagnostic criteria
for and were ultimately diagnosed with PANDAS. Sixty-two percent
(n513) of the patients met two or fewer of the four aforementioned
requirements. Two referrals (9.5%), in fact, did not have either
clinically diagnosed OCD or a tic disorder. In terms of not fulfilling
other diagnostic requirements, 23.8% (n55) of all referrals were under
the age of 3 years or over the age of 12 years, 28.6% (n56) did not
have a documented GASI, 42.9% (n59) had no temporal association
between a GASI and symptom onset of less than 6 weeks, and 76.2%
(n516) did not display waxing/waning of symptoms associated with
multiple GASIs. Interestingly, there were no patients without a final
diagnosis of PANDAS who experienced episodic waxing and waning
of symptoms in accordance with multiple GASIs.
Out of all the referrals, 38.1% (n58) had a major psychiatric disorder:
these included disorders in the autism spectrum, clinically diagnosed
depression, and catatonia. However, none of the patients with a final
diagnosis of PANDAS had a major psychiatric disorder (chi-square,
p,0.01). Interestingly, hallucinations were observed in 19% (n54) of
the patients irrespective of the final diagnosis of PANDAS; hallucina-
tions are documented as a condition associated with PANDAS.
Attention deficit disorder/attention deficit hyperactivity disorder
(ADD/ADHD) is documented to be a common co-morbidity among
PANDAS patients; this is confirmed by our data with 40% (n52) of the
PANDAS patients having an ADD/ADHD diagnosis.1,3,5,7,9
Discussion
Complicating diagnostic factors
Four of the five patients with a final diagnosis of PANDAS had at
least one documented instance of elevated anti-streptococcal titers:
Antistreptolysin O titer, anti-DNase B, and/or streptozyme. The
patient without elevated titers is assumed to now have elevated titers
due to a recently documented GASI. However, 56.25% (n59) of the
patients who were not diagnosed with PANDAS had documented
elevation in anti-streptococcal titers as well. This is not surprising due
to the nature of the titers (indication of a past GASI) coupled with the
extremely common nature of GASIs in pediatric patients. In fact, it is
the overall prevalence of streptococcus that makes establishing a
causational relationship between GASI and PANDAS so difficult and
the diagnosis so controversial.7,8 Additionally, we do not routinely
follow anti-streptococcal titers since they have not been shown to
correlate with disease activity.
The emerging prevalence of disorders related to PANDAS, similar
disorders with non-GAS etiologies, increases ambiguity, making it
more difficult to establish diagnostic certainty. Childhood acute-onset
neuropsychiatric symptoms (CANS) presents with OCD or a tic
disorder but does not require a recent infection to precede the sudden
onset of symptoms. An additional broad-spectrum diagnosis, Pediatric
infection-triggered autoimmune neuropsychiatric disorders (PITAND),
is defined as an acute onset of symptoms preceded by an infection
other than GAS. These new disorders, which are also not clearly
defined, have not garnered the same amount of attention as PANDAS,
resulting in confusion and misdiagnoses.7,10
Management techniques
None of the patients referred to the University of Michigan Pediatric
Infectious Disease Clinic had an objective method for evaluating their
referral symptomatology prior to referral (e.g., documenting and
quantifying frequency and severity of symptoms), including the
patients who had received plasmapheresis, IVIG, and ECT. Our
approach to PANDAS is to coordinate care across all appropriate
disciplines, consisting of a combination of Infectious Disease,
Neurology, Behavioral Pediatrics, and/or Psychiatry. This combina-
tion depends on each patient’s presenting symptoms and is designed to
objectively explore the relationship between the referring symptoms
and the documentation/prevention of GASI. Three of the five
PANDAS patients have had documented improvement in responses
to anti-microbial treatment targeting GAS, one patient is on
prophylactic antibiotics against GAS with documented improvement,
and the final patient has had no known recurrences of GASI or
symptoms. We currently have not treated any PANDAS patients with
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IVIG, although there is a pending NIH study examining the efficacy of
IVIG for PANDAS patients.11,12 There is no documented evidence in
the literature that plasmapheresis or ECT are effective treatment
options in the management of PANDAS.8
PANDAS still remains a complex medical condition that, because of
its potential impact on the patient and their family, provokes
significant anxiety on both health care providers and patients. This
anxiety results in over-diagnosis and inconsistent referral patterns and
inappropriate management strategies. One of the major goals of our
department was to decrease patient and family anxiety so that they do
not pursue inappropriate management strategies.
Follow-up
Of the 16 patients in which we ruled out a PANDAS diagnosis, nine
received follow-up from Psychiatry and/or Neurology and did not
receive any treatment targeting PANDAS; three received follow-up
from Infectious Disease for treatment unrelated to PANDAS and did
not receive any treatment targeting PANDAS; two patients received















1 Yes M 7 0 1 1 1 1 1 1
2 Yes M 3 1 0 1 1 1 1 1
3 Yes M 7 1 1 1 1 1 1 1
4 Yes F 9 0 1 1 1 1 1 1
5 Yes F 6 0 1 0 1 1 1 1
M: 60% 6.4 40% 80% 80% 100% 100% 100% 100%
6 No F 13 0 1 1 0 1 0 0
7 No M 15 1 0 1 0 1 1 0
8 No F 6 0 1 1 1 0 0 0
9 No M 6 0 0 0 1 0 0 0
10 No M 2 0 1 1 0 1 1 0
11 No M 2 1 0 0 0 0 1 0
12 No F 3 0 0 0 1 1 0 0
13 No M 14 1 1 1 0 0 0 0
14 No M 7 0 1 0 1 1 0 0
15 No M 10 0 1 1 1 0 0 0
16 No F 7 1 0 1 1 1 1 0
17 No M 9 0 1 0 1 0 1 0
18 No F 8 0 1 1 1 1 0 0
19 No F 5 1 0 0 1 1 1 0
20 No M 12 1 0 0 1 1 1 0
21 No M 1 1 1 1 0 1 0 0
Yes: 23.8% M: 62.5% 7.2 43.8% 56.3% 56.3% 62.5% 56.3% 43.8% 0% *
Abbreviations: GASI, Group A Beta-hemolytic Streptococcal Infection; OCD, Obsessive Compulsive Disorder; PANDAS, Pediatric Autoimmune Neuropsychiatric
Disorder Associated with Streptococcal Infections.
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treatment at the University of Michigan Hospital and Health Systems
by other departments for unrelated medical conditions and did not
receive any treatment targeting PANDAS; one patient has not received
follow-up from any department at the University of Michigan and it is
unknown if they received any PANDAS treatment outside of our
system; one patient moved to Shanghai, and Neurology was able to
establish a non-PANDAS-related treatment plan; whether this plan
was executed by the patient’s family is unknown.
Of the five patients ultimately diagnosed with PANDAS: one patient
followed-up with Psychiatry and received a tonsillectomy due to
recommendation from otolaryngology with no further symptoms; one
patient followed-up with Infectious Diseases mainly via email with no
known PANDAS-related treatment; one patient followed-up with
Infectious Diseases but elected to receive IVIG at an outside
institution; one patient did not receive follow-up with Infectious
Disease, Neurology, or Psychiatry at the University of Michigan, but
per note from Orthopedic Surgery for unrelated treatment, the patient
did not receive any PANDAS treatment from an outside location; one
patient received follow-up outside the University of Michigan system
and was lost to follow-up.
Table 2. Psychiatric Findings for PANDAS Referrals
Patient No. PANDAS Autism Spectrum Additional Psychiatric Disorders Hallucinations AD(H)D
1 Yes 0 0 1 1
2 Yes 0 0 0 0
3 Yes 0 0 0 1
4 Yes 0 0 0 0
5 Yes 0 0 0 0
0%* 0%* 20% 40%
6 No 0 0 0 0
7 No 1 Depression, catatonia 1 0
8 No 1 0 0 0
9 No 1 0 0 1
10 No 0 0 0 0
11 No 1 0 0 1
12 No 1 0 0 1
13 No 0 Depression, catatonia 0 1
14 No 0 0 0 0
15 No 1 0 0 1
16 No 0 0 1 0
17 No 0 0 0 0
18 No 0 0 0 0
19 No 0 0 0 0
20 No 0 Depression 1 0
21 No 0 0 0 0
37.5% 18.85% 18.8% 31.3%
Abbreviations: AD(H)D, Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder; PANDAS, Pediatric Autoimmune Neuropsychiatric Disorder
Associated with Streptococcal Infections.
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While Infectious Disease/Immunology may be most adept at
managing the GASI, they are not trained for managing the primary
symptoms associated with PANDAS. Thus, when necessary, the
primary role for Pediatric Infectious Diseases should be the provision
of a GASI-free period during which time the other specialties can
evaluate the impact this has on the PANDAS symptoms. The initial
referring team (i.e., the child’s primary care physician) carries out
symptomatic management of GASI with infectious diseases providing
the GAS medications and course of treatment; this is a similar
approach to treatment of rheumatic fever with GAS prophylaxis. This
approach has been most effective with the patients when PANDAS is
being ruled out (approximately 80% of the time). The other
appropriate specialty, based on primary symptoms, must first develop
a quantitative objective scale in order to evaluate the effect if any of the
GASI on symptom severity. They also have primary responsibility to
manage the neurologic symptoms and provide alternative diagnoses
once PANDAS has been ruled out.
Limitations and strengths
The limitations of this study include that it is a retrospective study and
there are a limited number of patients involved in the study. Had this
been a prospective study, patient satisfaction scores could have been
generated to objectively assess the team approach. Additionally, the
sample size of patients with major psychiatric disorders was small (n58).
The strengths of our study include finding the current deficit in
physician knowledge about PANDAS, which we will attempt to remedy
via teaching modules for pediatric residents at the University of
Michigan Hospital and Health Systems. The use of objective symptom
monitoring and a collaborative team approach of these patients will lead
to more focused and increased quality care; ultimately preventing
unnecessary, and potentially harmful, treatment of patients.
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